F.B.C. (Shanghai) Pharmaceutical Technology Co., LTD., founded in 2014, located in Shanghai Zhang Jiang high tech Park, is the first domestic company focusing on the r&d and industrialization of high-end nano drug delivery system. In May 2017, FBC signed a strategic cooperation agreement with NPERC for pharmaceutical preparations to build a high-end nano-drug innovation platform, which will provide customers with high-quality nano-drug encapsulation solutions and CMC pharmaceutical services, and help pharmaceutical companies accelerate the process of new drug research and development and improve the clinical efficacy of drugs.
Our core team members have accumulated 10 to 15 years of rich experience in nano drug delivery system R&D, QA and RA in other leading domestic research institutes such as Chinese Academy of Sciences Shanghai Institute of Materia Medica, and have more than 30 patents for nanomaterials.
With technical support from overseas (Japan Q.P. and NFC) and rich experience in research and development of nanoparticle delivery systems, the team has set up a pilot platform for research and development for the nano emulsion injection and meet the requirements of the GMP (200-800 L/batch) in three years. We completed the industrialization of the transformation of seven generic nano delivery system, and a pilot study of new nano delivery system. Product quality has achieved the domestic leading level.
It is one of the company's long-term development strategies to develop patented technologies based on high-end nanomaterials and actively seek technological innovation and product innovation in various fields. FBC will adhere to the customer-oriented service concept, with the help of international technical support, strive to provide more and more customers with high-quality nano drug packaging and CMC pharmacal service.